The University of Texas Medical Branch at Galveston to Receive Exclusive License for Rift Valley Fever Vaccine

Summary

The U.S. government has announced its intention to grant an exclusive, royalty-bearing license to The University of Texas Medical Branch at Galveston for the development of a human vaccine against Rift Valley fever, a licensed live-attenuated virus.